Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation

被引:26
作者
Nyati, Mukesh K.
Feng, Felix Y.
Maheshwari, Divya
Varambally, Sooryanarayana
Zielske, Steven P.
Ahsan, Aarif
Chun, Patrick Y.
Arora, Vinay A.
Davis, Mary A.
Jung, Mira
Ljungman, Mats
Canman, Christine E.
Chinnaiyan, Arul M.
Lawrence, Theodore S.
机构
[1] Univ Michigan, Med Ctr, Dept Radiat Oncol, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Georgetown Univ, Sch Med, Dept Radiat Med, Washington, DC USA
关键词
D O I
10.1158/0008-5472.CAN-06-1935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ataxia telangiectasia mutated (ATM) kinase plays a crucial role in the cellular response to DNA damage and in radiation resistance. Although much effort has focused on the relationship between ATM and other nuclear signal transducers, little is known about interactions between ATM and mitogenic signaling pathways. In this study, we show a novel relationship between ATM kinase and extracellular signal-regulated kinase 1/2 (ERK1/2), a key mitogenic stimulator. Activation of ATM by radiation down-regulates phospho-ERK1/2 and its downstream signaling via increased expression of mitogen-activated protein kinase phosphatase MKP-1 in both cell culture and tumor models. This dephosphorylation of ERK1/2 is independent of epidermal growth factor receptor (EGFR) activity and is associated with radioresistance. These findings show a new function for ATM in the control of mitogenic pathways affecting cell signaling and emphasize the key role of ATM in coordinating the cellular response to DNA damage.
引用
收藏
页码:11554 / 11559
页数:6
相关论文
共 28 条
[1]  
ALESSI DR, 1993, ONCOGENE, V8, P2015
[2]   ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage [J].
Bar-Shira, A ;
Rashi-Elkeles, S ;
Zlochover, L ;
Moyal, L ;
Smorodinsky, NI ;
Seger, R ;
Shiloh, Y .
ONCOGENE, 2002, 21 (05) :849-855
[3]   Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry [J].
Brunet, A ;
Roux, D ;
Lenormand, P ;
Dowd, S ;
Keyse, S ;
Pouysségur, J .
EMBO JOURNAL, 1999, 18 (03) :664-674
[4]   Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma [J].
Chun, PY ;
Feng, FY ;
Scheurer, AM ;
Davis, MA ;
Lawrence, TS ;
Nyati, MK .
CANCER RESEARCH, 2006, 66 (02) :981-988
[5]   EXTRACELLULAR SIGNAL-REGULATED KINASES - ERKS IN PROGRESS [J].
COBB, MH ;
BOULTON, TG ;
ROBBINS, DJ .
CELL REGULATION, 1991, 2 (12) :965-978
[6]   The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis [J].
Falck, J ;
Mailand, N ;
Syljuåsen, RG ;
Bartek, J ;
Lukas, J .
NATURE, 2001, 410 (6830) :842-847
[7]  
FENG FY, 2006, ONCOGENE 1204
[8]   MEAN INACTIVATION DOSE - A USEFUL CONCEPT FOR INTERCOMPARISON OF HUMAN CELL-SURVIVAL CURVES [J].
FERTIL, B ;
DERTINGER, H ;
COURDI, A ;
MALAISE, EP .
RADIATION RESEARCH, 1984, 99 (01) :73-84
[9]   The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling [J].
Huang, HJS ;
Nagane, M ;
Klingbeil, CK ;
Lin, H ;
Nishikawa, R ;
Ji, XD ;
Huang, CM ;
Gill, GN ;
Wiley, HS ;
Cavenee, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2927-2935
[10]   EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog [J].
Kar, S ;
Adachi, T ;
Carr, BI .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) :356-364